Clinical Trial

Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization

Study acronym: HALO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 14, 2022 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The majority (\>80%) of strokes are of ischemic etiology, of which ≈15% to 20% are attributable to atherosclerosis of the extracranial carotid arteries. The primary goal in carotid artery revascularization is to prevent stroke in patients with carotid artery stenosis. Treatment options including carotid endarterectomy (CEA) and carotid artery stenting (CAS). Hence, the investigators aim to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in terms of long-term prognostic endpoints. Also, CEA and CAS result in different postoperative geometric features of carotid arteries that entail relevant modifications of rheological parameters, that may be associated with the risk of local complications and carotid artery restenosis. Finally, long-term and sustained cognitive benefits after carotid artery revascularization need further research and evidence.
Trial Details
NCT Number NCT05539781
Lead Sponsor Beijing Friendship Hospital
Conditions Carotid Artery Diseases, Carotid Artery Stenosis, Cerebrovascular; Disorder, Arteriosclerotic, Cardiovascular Diseases, Nervous System Diseases
Enrollment 200 participants
Start Date 2020-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-09-14